AZD0486 1L Therapy for Elderly or Unfit Participants with LBCL

Trial Identifier: D7402C00001
Sponsor: AstraZeneca
Start Date: November 2025
Primary Completion Date: June 2030
Study Completion Date: July 2033

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Melbourne, AU, 3000
AU Nedlands, AU, 6009
BE Antwerpen, BE, 2030
BE Bruxelles, BE, 1200
BE Gent, BE, 9000
BE Leuven, BE, 3000
BE Roeselare, BE, 8800
BE Yvoir, BE, 5530
BR Porto Alegre, BR, 90035-003
BR São Paulo, BR, 05652000
CA, Alberta Calgary, Alberta, CA, T2N 5G2
CA, Ontario Ottawa, Ontario, CA, K1H 7W9
CN Beijing, CN, 100730
CN Changchun, CN, 130021
CN Chengdu, CN, 610041
CN Nanchang, CN, 330000
CN Shandong, CN
CN Shanghai, CN, 200003
CN Shanghai, CN, 20032
GB London, GB, NW1 2PG
GB Newcastle upon Tyne, GB, NE7 7AF
HK Hong Kong, HK, 999077
HK Lai Chi Kok, HK
JP Bunkyo-ku, JP, 113-8677
JP Koto-ku, JP, 135-8550
JP Osaka-shi, JP, 545-8586
JP Sunto-gun, JP, 411-8777
JP Yamagata-shi, JP, 990-9585
JP Yokohama-shi, JP, 241-8515
KR Seoul, KR, 03080
KR Seoul, KR, 5505
PL Kielce, PL, 25-734
PL Krakow, PL, 30-727
PL Łódź, PL, 93-513
PL Lublin, PL, 20-090
PL Wroclaw, PL, 50-367
TR Ankara, TR, 06620
TR Antalya, TR, 07025